持続血糖モニタリングの世界市場の機会と2031年までの戦略Including：1) コンポーネント別1）コンポーネント別：インスリンポンプ；センサー；トランスミッター；レシーバー2）用途別：1型糖尿病患者；2型糖尿病患者；妊娠糖尿病患者1）用途別：1型糖尿病患者、2型糖尿病患者、妊娠糖尿病、重症患者3）用途別：病院、在宅ケア診断：病院; 在宅ケア診断薬対象：Abbott Laboratories; Dexcom, Inc; Medtronic plc; Senseonics Holdings, Inc; A. Menarini Diagnostics

Continuous Blood Glucose Monitoring Global Market Opportunities And Strategies To 2031Including: 1) By Components: Insulin Pumps; Sensors; Transmitters; Receivers 2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients 3) By Application: Hospitals; Homecare DiagnosticsCovering: Abbott Laboratories; Dexcom, Inc.;Medtronic plc; Senseonics Holdings, Inc.; A. Menarini Diagnostics

この調査レポートは、COVID-19の閉鎖から立ち上がる継続的血糖モニタリングの世界市場を評価するために必要な重要な情報を戦略家、マーケティング担当者、経営幹部に提供しています。購入の理由 - 12地域を... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年1月31日	US$5,000 シングルユーザライセンスライセンス・価格情報注文方法はこちら	299	英語

サマリー

この調査レポートは、COVID-19の閉鎖から立ち上がる継続的血糖モニタリングの世界市場を評価するために必要な重要な情報を戦略家、マーケティング担当者、経営幹部に提供しています。

購入の理由
- 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がコロナウイルスによってどのような影響を受けているのか、また、ウイルスの影響が和らぐにつれて市場がどのように浮上し、成長していくのかを理解することができます。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定します。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。

説明
継続的血糖モニタリングの最大かつ急成長市場はどこか？経済全体、人口動態、他の類似市場との関連は？今後の市場を形成する力は何か？The Business Research Companyの継続的血糖モニタリング世界市場レポートでは、これらすべての質問とその他多くの質問に回答しています。
当レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略を網羅しています。市場の歴史をたどり、地域別の市場成長を予測しています。また、同市場をより広範な継続的血糖モニタリング市場との関連において位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています。
-イントロダクションと市場の特徴 - 市場区分の簡単な紹介、血糖値モニター市場の定義と説明
-主要動向 - 世界の継続的血糖モニタリング市場を形成している主要動向にハイライトを当てます。また、今後の市場動向についても解説します。
-世界の市場規模と成長-世界の過去（2016-2021年）と予測（2021-2026年）、（2026-2031年）の市場価値、過去と予測期間における市場の成長を支え、コントロールする推進要因と阻害要因。
-地域別・国別分析-過去（2016-2021年）と予測（2021-2026年）、（2026-2031年）の市場価値、地域別の成長と市場シェアの比較。
-市場セグメンテーション-市場におけるコンポーネント別、用途別、エンドユーザー別の市場価値（2016-2031年）と各セグメント別の分析を収録。
-地域別の市場規模と成長-地域別の市場規模（2021年）、過去（2016年～2021年）と予測（2021年～2026年）、（2026年～2031年）の市場価値、地域内の国々の成長と市場シェア比較を掲載しています。本レポートには、アジア太平洋地域、西欧地域、東欧地域、北米地域、南米地域、および各地域内の主要国に関する情報が含まれています。
-競合情勢 - 市場の競合情勢、推定市場シェア、主要プレイヤーの会社プロファイルの詳細。
-主要なM&A - レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。このセクションでは、近年の市場を形成したM&Aに関する主要な財務情報を提供します。
-市場機会と戦略 - 調査結果に基づく市場機会と戦略について、国やセグメントごとの成長機会やそれらの市場で取るべき戦略に関する情報を交えて記述しています。
-結論と推奨事項 - 製品/サービスの提供、地理的拡大、マーケティング戦略、ターゲットグループなどの観点から、継続的な血糖モニタリングプロバイダーへの推奨事項を記載しています。
-付録 - このセクションには、本レポートで使用されているNAICSコード、略語、通貨コードの詳細が含まれています。

スコープ

対象市場
1) コンポーネント別インスリンポンプ；センサー；トランスミッター；レシーバー
2) アプリケーション別1型糖尿病患者、2型糖尿病患者、妊娠糖尿病、重症患者
3) アプリケーション別病院；在宅診断；その他エンドユーザー

言及された企業Abbott Laboratories; Dexcom, Inc; Medtronic plc; Senseonics Holdings, Inc; A. Menarini Diagnostics

国中国、オーストラリア、インド、インドネシア、日本、韓国、アメリカ、ブラジル、フランス、ドイツ、イギリス、ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年、予測10年

データ関連市場に対する市場規模および成長率、GDP比率、一人当たり支出、継続的血糖モニタリング指標の比較。

データ区分：国別および地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：レポート中のデータおよび分析はエンドノートを使用しています。

当レポートでは、持続血糖モニタリング市場について解説し、2016-2021年（過去期間）、2021-2026年（予測期間）、さらに2026-2031年の予測を掲載しています。各地域および各地域内の主要経済圏の市場を評価しています。

世界の持続血糖モニタリング市場は、2016年以降19.7%の複合年間成長率（CAGR）で成長し、2021年には約56億8,450万ドルに達した。同市場は、2021年の56億8450万ドルから2026年には127億2660万ドルに17.5%の成長率で拡大すると予測される。その後2026年からはCAGR19.5%で成長し、2031年には310億5030万ドルに達すると予想される。

歴史的期間の成長は、肥満の増加、新興市場の成長、急速な都市化、医療費の増加、老人人口の増加によってもたらされた。歴史的期間の成長にマイナスの影響を与えた要因は、医療アクセスの低さ、規制上の課題、糖尿病と持続グルコースモニタリングシステムに関する認識不足であった。

今後は、糖尿病の罹患率の増加、持続血糖モニタリングシステムの使用の増加、政府のイニシアチブの増加、慢性疾患の増加が成長を促進する。今後の持続血糖モニタリング市場の成長を阻害する要因としては、高コストや金利の上昇などが挙げられる。

持続血糖モニタリング市場は、コンポーネント別にインスリンポンプ、センサー、トランスミッター、レシーバーに区分される。センサー市場は、コンポーネント別にセグメント化された持続血糖モニタリング市場の中で最大のセグメントであり、2021年には全体の50.6%を占めた。今後、センサーセグメントは、コンポーネント別にセグメント化された持続血糖モニタリング市場において、2021～2026年のCAGRが18.10%で、最も急成長するセグメントとなる見込みである。

持続血糖モニタリング市場は、用途別に1型糖尿病患者、2型糖尿病患者、妊娠糖尿病患者、重症患者などに区分される。2型糖尿病患者市場は、アプリケーション別にセグメント化された持続血糖モニタリング市場の中で最大のセグメントであり、2021年には全体の85.3％を占めた。今後、2型糖尿病患者セグメントは、2021-2026年のCAGR17.7%で、アプリケーション別にセグメント化された持続血糖モニタリング市場において最も急成長するセグメントとなる見込みである。

持続血糖モニタリング市場は、エンドユーザー別に病院、在宅ケア診断、その他のエンドユーザーに区分される。在宅ケア診断市場は、エンドユーザー別に区分した持続血糖モニタリング市場において最大のセグメントであり、2021年には全体の50.0%を占めた。今後、エンドユーザー別にセグメント化された持続血糖モニタリング市場において、在宅ケア診断部門が2021～2026年のCAGR 18.1％で最も急成長する見込みである。

持続血糖モニタリング市場の最大地域は北米で、2021年には全体の42.3%を占めた。次いでアジア太平洋地域、西ヨーロッパ地域、その他の地域と続く。今後、持続血糖モニタリング市場で最も急成長する地域は北米と西欧で、それぞれCAGR19.3%と17.8%で成長する。これに続くのはアジア太平洋地域と南米で、それぞれCAGR 15.9％と15.4％の成長が見込まれる。

世界の持続血糖モニタリング市場は、少数の大手企業に集中している。2021年の市場全体の93.30%は競合上位10社で占められている。これは、特定の地域の顧客にサービスを提供する多数のローカルプレーヤーが市場に存在するためと考えられる。最近の技術革新は、各社の市場プレゼンス強化に貢献している。Abbott Laboratories Holdings, Inc.が市場シェア41.66%で最大の競合企業であり、Dexcom, Inc.が38.77%、Medtronic plcが12.34%、Senseonics Holdings, Inc.が0.24%で続いている。24%、A. Menarini Diagnosticsが0.19%、Medtrum Technologies, Inc.が0.04%、SB Solutionsが0.02%、DiaMonTech AGが0.02%、Nemaura Medical Inc.が0.01%、Metronom Healthが0.01%である。その他のプレーヤーは、Veri、Zhejiang POCTech Co.Ltd.、WaveForm Diabetes（これらの収益は二次を通じて入手できない）、およびその他のプレーヤーである。

コンポーネント別にセグメント化された持続的血糖モニタリング市場における最大のビジネスチャンスは、2026年までに37億3,420万ドルの世界年間売上高を獲得するセンサーセグメントで発生する。アプリケーション別にセグメント化された持続血糖モニタリング市場の上位機会は、2026年までに世界年間売上高61億2400万ドルを獲得する2型糖尿病患者セグメントに生じる。エンドユーザー別に区分した持続血糖モニタリング市場において、2026年までに世界の年間売上高が36億9,000万ドルに達する在宅ケア診断セグメントで最大のビジネスチャンスが生まれるだろう。持続血糖モニタリング市場規模は、米国で24億7380万ドルと最も増加する。

持続血糖モニタリング市場の市場トレンドに基づく戦略には、新製品の発売、新技術の開発、事業への新規投資が含まれる。

持続血糖モニタリング市場におけるプレーヤーが採用する戦略には、高度な機能を備えた新製品をさまざまな地域で発売することに注力すること、製品を商品化するために同じ事業を展開する企業とパートナーシップを結ぶことによって製品ポートフォリオを強化することなどが含まれる。

ビジネスリサーチカンパニーは、機会を活用するために、持続血糖モニタリング市場の企業が、持続血糖モニタリングにおける人工知能の使用に焦点を当てること、新製品の発売に焦点を当てること、技術の進歩に焦点を当てること、新興市場で拡大すること、先進国市場に引き続き焦点を当てること、パートナーシップとコラボレーションに焦点を当てること、競争力のある価格の製品を提供すること、展示会やイベントに参加すること、企業間（B2B）プロモーションを引き続き利用すること、急成長するエンドユーザーを引き続きターゲットにすること、急成長するアプリケーションに焦点を当てることを推奨する。

ページTOPに戻る

1.Executive Summary
2.Table of Contents
3.List of Figures
4.List of Tables
5.Report Structure
6.Introduction and Market Characteristics
6.1.General Market Definition
6.2.Summary
6.3.Continuous Blood Glucose Monitoring Market Definition and Segmentations
6.4.Market Segmentation By Components
6.4.1.Insulin Pumps
6.4.2.Sensors
6.4.3.Transmitters
6.4.4.Receivers
6.5.Market Segmentation By Application
6.5.1.Type 1 Diabetic Patients
6.5.2.Type 2 Diabetic Patients
6.5.3.Gestational Diabetes
6.5.4.Critical Care Patients
6.6.Market Segmentation By End User
6.6.1.Hospitals
6.6.2.Homecare Diagnostics
6.6.3.Other End Users
7.Major Market Trends
7.1.New Product Launches
7.2.New Technology Development
7.3.Increasing Investments
8.Global Market Size And Growth
8.1.Market Size
8.2.Historic Market Growth, 2016 – 2021, Value ($ Million)
8.2.1.Market Drivers 2016 – 2021
8.2.2.Market Restraints 2016 – 2021
8.3.Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
8.3.1.Market Drivers 2021 – 2026
8.3.2.Market Restraints 2021 – 2026
9.Global Market Segmentation
9.1.Global Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.2.Global Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.3.Global Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10.Global Market, Regional And Country Analysis
10.1.Global Continuous Blood Glucose Monitoring Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10.2.Global Continuous Blood Glucose Monitoring Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.Asia-Pacific Market
11.1.Summary
11.2.Market Overview
11.2.1.Region Information
11.2.2.Market Information
11.2.3.Background Information
11.2.4.Government Initiatives
11.2.5.Regulations
11.2.6.Regulatory Bodies
11.2.7.Major Associations
11.2.8.Taxes Levied
11.2.9.Corporate Tax Structure
11.2.10.Investments
11.2.11.Major Companies
11.3.Asia-Pacific Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.4.Asia-Pacific Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.5.Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.6.Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.7.Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.8.Asia Pacific Continuous Blood Glucose Monitoring Market: Country Analysis
11.9.China Market
11.10.Summary
11.11.Market Overview
11.11.1.Country Information
11.11.2.Market Information
11.11.3.Background Information
11.11.4.Government Initiatives
11.11.5.Regulations
11.11.6.Regulatory Bodies
11.11.7.Major Associations
11.11.8.Taxes Levied
11.11.9.Corporate Tax Structure
11.11.10.Investments
11.11.11.Major Companies
11.12.China Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.13.China Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.14.China Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.15.China Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.16.China Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.17.India Market
11.18.India Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.19.India Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.20.India Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.21.India Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.22.India Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.23.Japan Market
11.24.Japan Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.25.Japan Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.26.Japan Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.27. Japan Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.28. Japan Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Market
11.30. Australia Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.31. Australia Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.32. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.33. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.34. Australia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.37. Indonesia Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.38. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.39. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.40. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.43. South Korea Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.44. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.45. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.46. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulatory bodies
12.2.6. Major Associations
12.2.7. Taxes Levied
12.2.8. Corporate Tax Structure
12.2.9. Investments
12.2.10. Major Companies
12.3. Western Europe Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.4. Western Europe Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.5. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.8. Western Europe Continuous Blood Glucose Monitoring Market: Country Analysis
12.9. UK Market
12.10. UK Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.11. UK Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.12. UK Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.13. UK Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.14. UK Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.15. Germany Market
12.16. Germany Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.17. Germany Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.18. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.19. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.20. Germany Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.21. France Market
12.22. France Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.23. France Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.24. France Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.25. France Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.26. France Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.4. Eastern Europe Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.5. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.8. Eastern Europe Continuous Blood Glucose Monitoring Market: Country Analysis
13.9. Russia Market
13.10. Russia Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.11. Russia Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.12. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.13. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.14. Russia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Body
14.2.7. Major Associations
14.2.8. Taxes levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.4. North America Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.5. North America Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.8. North America Continuous Blood Glucose Monitoring Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.13. USA Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.14. USA Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.15. USA Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.16. USA Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.4. South America Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.5. South America Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.8. South America Continuous Blood Glucose Monitoring Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.11. Brazil Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.12. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.13. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.14. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
16.4. Middle East Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
16.5. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.7. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Major Companies
17.3. Africa Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
17.4. Africa Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
17.5. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.7. Africa Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. Abbott Laboratories
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Dexcom, Inc.
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Medtronic plc
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Senseonics Holdings, Inc.
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. A. Menarini Diagnostics
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
18.7. New Companies Entering The Market
18.7.1. GlucoTrack, Inc.
18.7.2. LifeScan
18.7.3. Graphwear
18.7.4. Infinovo
18.7.5. GlucoRx
18.7.6. Integrated Medical Sensors
18.7.7. i-SENS
18.7.8. Pacific Diabetes Technologies
18.7.9. WaveForm Technologies
18.7.10. Ascensia
18.7.11. GluSense
18.7.12. GlySens
18.7.13. PercuSense
18.7.14. Biolinq
18.7.15. Indigo Diabetes
18.7.16. Echo Therapeutics
19. Key Mergers and Acquisitions
19.1. Glooko Acquired Xbird
19.2. Eli Lily And Company Acquired Promoter Technologies
19.3. Carbon Health Acquired Steady Health
19.4. Medtronic Acquired Companion Medical
19.5. One Drop Acquired Sano Intelligence Inc
20. Global Continuous Blood Glucose Monitoring Market Opportunities And Strategies
20.1. Global Continuous Blood Glucose Monitoring Market In 2026 – Countries Offering Most New Opportunities
20.2. Global Continuous Blood Glucose Monitoring Market In 2026 – Segments Offering Most New Opportunities
20.3. Global Continuous Blood Glucose Monitoring Market In 2026 – Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21.Continuous Blood Glucose Monitoring Market, Conclusions And Recommendations
21.1.Conclusions
21.2.Recommendations
21.2.1.Product
21.2.2.Place
21.2.3.Price
21.2.4.Promotion
21.2.5.People
22.Appendix
22.1.Market Data Sources
22.2.Research Methodology
22.3.Currencies
22.4.The Business Research Company
22.5.Copyright and Disclaimer

ページTOPに戻る

Table of Contents

Summary

Continous Blood Glucose Monitoring Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global continous blood glucose monitoring market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest-growing market for continous blood glucose monitoring? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The continous blood glucose monitoring market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider continous blood glucose monitoring market; and compares it with other markets.

The report covers the following chapters
•Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the continous blood glucose monitoring market.
•Key Trends - Highlights the major trends shaping the global continous blood glucose monitoring market. This section also highlights likely future developments in the market.
•Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
•Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region.
•Market Segmentation - Contains the market values (2016-2031) and analysis for each segment by components, by application and by end user in the market.
•Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and major countries within each region.
•Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
•Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
•Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
•Conclusions And Recommendations - Includes recommendations for continous blood glucose monitoring providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
•Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:
1) By Components: Insulin Pumps; Sensors; Transmitters; Receivers
2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients
3) By Application: Hospitals; Homecare Diagnostics; Other End Users

Companies Mentioned: Abbott Laboratories; Dexcom, Inc.; Medtronic plc; Senseonics Holdings, Inc.; A. Menarini Diagnostics

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; continous blood glucose monitoring indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report describes and explains the continuous blood glucose monitoring market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The global continuous blood glucose monitoring market reached a value of nearly $5,684.5 million in 2021, having grown at a compound annual growth rate (CAGR) of 19.7% since 2016. The market is expected to grow from $5,684.5 million in 2021 to $12,726.6 million in 2026 at a rate of 17.5%. The market is then expected to grow at a CAGR of 19.5% from 2026 and reach $31,050.3 million in 2031.

Growth in the historic period resulted from increasing obesity, emerging markets growth, rapid urbanization, increased healthcare expenditure and increased geriatric population. Factors that negatively affected growth in the historic period were low healthcare access, regulatory challenges and lack of awareness about diabetes and continuous glucose monitoring systems.

Going forward, increased incidence of diabetes, increasing use of continuous blood glucose monitoring systems, increasing government initiatives and an increase in chronic diseases will drive the growth. Factors that could hinder the growth of the continuous blood glucose monitoring market in the future include high cost and a rise in interest rates.

The continuous blood glucose monitoring market is segmented by components into insulin pumps, sensors, transmitters, and receivers. The sensors market was the largest segment of the continuous blood glucose monitoring market segmented by components, accounting for 50.6% of the total in 2021. Going forward, the sensors segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by components, at a CAGR of 18.10% during 2021-2026.

The continuous blood glucose monitoring market is segmented by application into type 1 diabetic patients, type 2 diabetic patients, gestational diabetes and critical care patients. The type 2 diabetic patients market was the largest segment of the continuous blood glucose monitoring market segmented by application, accounting for 85.3% of the total in 2021. Going forward, the type 2 diabetic patients segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by application, at a CAGR of 17.7% during 2021-2026.

The continuous blood glucose monitoring market is segmented by end user into hospitals, homecare diagnostics and other end users. The homecare diagnostics market was the largest segment of the continuous blood glucose monitoring market segmented by end user, accounting for 50.0% of the total in 2021. Going forward, the homecare diagnostics segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by end user, at a CAGR of 18.1% during 2021-2026.

North America was the largest region in the continuous blood glucose monitoring market, accounting for 42.3% of the total in 2021. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the continuous blood glucose monitoring market will be North America and Western Europe where growth will be at CAGRs of 19.3% and 17.8% respectively. These will be followed by Asia Pacific and South America where the markets are expected to grow at CAGRs of 15.9% and 15.4% respectively.

The global continuous blood glucose monitoring market is concentrated, with a few large players. The top ten competitors in the market made up to 93.30% of the total market in 2021. This can be due to the existence of number of local players in the market serving customers in particular geographies. Technological innovations in the recent past helped the companies to strengthen their market presence. Abbott Laboratories Holdings, Inc. was the largest competitor with 41.66% share of the market, followed by Dexcom, Inc. with 38.77%, Medtronic plc with 12.34%, Senseonics Holdings, Inc. with 0.24%, A. Menarini Diagnostics with 0.19%, Medtrum Technologies, Inc. with 0.04%, SB Solutions with 0.02%, DiaMonTech AG with 0.02%, Nemaura Medical Inc. with 0.01%, and Metronom Health with 0.01%. The other players are Veri, Zhejiang POCTech Co.,Ltd., WaveForm Diabetes (revenue is not available for these through secondary) and other players.

The top opportunities in the continuous blood glucose monitoring market segmented by components will arise in the sensors segment, which will gain $3,734.2 million of global annual sales by 2026. The top opportunities in the continuous blood glucose monitoring market segmented by application will arise in the type 2 diabetic patients segment, which will gain $6,124.0 million of global annual sales by 2026. The top opportunities in the continuous blood glucose monitoring market segmented by end user will arise in the homecare diagnostics segment, which will gain $3,690.0 million of global annual sales by 2026. The continuous blood glucose monitoring market size will gain the most in USA at $2,473.8 million.

Market-trend-based strategies for the continuous blood glucose monitoring market include new product launches, new technology development and new investments in business.

Player-adopted strategies in the continuous blood glucose monitoring market include focus on launching new products with advanced features and in different geographic areas and strengthening product portfolio by forming partnerships with companies having same business to commercialize products.

To take advantage of the opportunities, The Business Research Company recommends the companies in the continuous blood glucose monitoring market to focus on use of artificial intelligence in continuous blood glucose monitoring, focus on new product launches, focus on technology advancements, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use business-to-business (B2B) promotions, continue to target fast-growing end-users and focus on fast-growing applications.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

The Business Research Company　(TBRC)社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（blood glucose）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

The Business Research Company (TBRC)社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（blood glucose）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC)社の医療機器分野での最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?